Difference between revisions of "Part:BBa K2066025:Experience"

 
 
Line 1: Line 1:
 +
All Ribozyme constructs were sequence confirmed using Sanger sequencing.
  
−
__NOTOC__
+
As our BBa_K2066030 and BBa_K2066031 ( without RiboJ constructs) already showed a collapsed transfer function we did not need to pursue characterizing the + RiboJ condition for our pTac promoter variants.  
−
This experience page is provided so that any user may enter their experience using this part.<BR>Please enter
+
−
how you used this part and how it worked out.
+
  
 
===Applications of BBa_K2066025===
 
===Applications of BBa_K2066025===

Latest revision as of 05:50, 29 October 2016

All Ribozyme constructs were sequence confirmed using Sanger sequencing.

As our BBa_K2066030 and BBa_K2066031 ( without RiboJ constructs) already showed a collapsed transfer function we did not need to pursue characterizing the + RiboJ condition for our pTac promoter variants.

Applications of BBa_K2066025

User Reviews

UNIQed851327bdf5b956-partinfo-00000000-QINU UNIQed851327bdf5b956-partinfo-00000001-QINU